Skip to content

Distal 22q11 2 Microduplication Syndrome C4706942

Published: July 22, 2026Updated: August 25, 2026

A chromosomal condition where a small extra piece of chromosome 22 is present. Features vary widely and may include developmental differences and various health concerns. Management addresses specific symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Congenital heart defect

(cardiovascular)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(nervous_system)

Cleft palate

(head_and_neck)

Immune deficiency

(immune_system)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive cardiac evaluation

Initial and ongoing cardiac assessment including echocardiography to screen for congenital heart defects and structural abnormalities associated with the microduplication.

monitoring
2

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Psychiatric monitoring and intervention

Regular psychiatric assessment for early detection and management of psychiatric manifestations including anxiety, autism spectrum features, and psychotic symptoms.

psychological

Additional treatment options

Developmental therapy services

Occupational and speech therapy interventions addressing developmental delays, speech-language difficulties, and motor coordination challenges.

physical_therapy

Immunological assessment

Evaluation of immune function given the association with 22q11.2 region and potential for immunodeficiency affecting infection susceptibility.

monitoring

Genetic counseling and family support

Genetic counseling services for families to understand the microduplication inheritance pattern and recurrence risks within the family.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Distal 22q11 2 Microduplication Syndrome C4706942?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Distal 22q11 2 Microduplication Syndrome C4706942. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy